Cargando…
Melatonin to prevent delirium in patients with advanced cancer: a double blind, parallel, randomized, controlled, feasibility trial
BACKGROUND: Delirium is highly problematic in palliative care (PC). Preliminary data indicate a potential role for melatonin to prevent delirium, but no randomized controlled trials (RCTs) are reported in PC. METHODS: Patients aged ≥18 years, with advanced cancer, admitted to an inpatient Palliative...
Autores principales: | Lawlor, Peter G., McNamara-Kilian, Marie T., MacDonald, Alistair R., Momoli, Franco, Tierney, Sallyanne, Lacaze-Masmonteil, Nathalie, Dasgupta, Monidipa, Agar, Meera, Pereira, Jose L., Currow, David C., Bush, Shirley H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579814/ https://www.ncbi.nlm.nih.gov/pubmed/33087111 http://dx.doi.org/10.1186/s12904-020-00669-z |
Ejemplares similares
-
The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial
por: Bush, Shirley Harvey, et al.
Publicado: (2016) -
Clinical Assessment and Management of Delirium in the Palliative Care Setting
por: Bush, Shirley Harvey, et al.
Publicado: (2017) -
Delirium diagnosis, screening and management
por: Lawlor, Peter G., et al.
Publicado: (2014) -
Biologic correlates associated with poor functional recovery after delirium: A nested prospective cohort study
por: Dasgupta, Monidipa, et al.
Publicado: (2023) -
Quality of clinical practice guidelines in delirium: a systematic appraisal
por: Bush, Shirley H, et al.
Publicado: (2017)